Selection of vasoactive agents in septic cardiomyopathy

doi:10.3877/cma.j.issn.2096-1537.2020.02.004

Abstract

Abstract:

Septic cardiomyopathy is an acute syndrome of cardiac dysfunction that is unrelated to cardiac ischemia in patients with sepsis. It is characterized by ventricular dilation, myocardial contraction weakening, and reversible cardiac dysfunction. There have been no standards for the diagnosis and therapy of septic cardiomyopathy, and the treatment strategy currently used for septic cardiomyopathy is the same as that for sepsis without cardiomyopathy. When selecting vasoactive agents, the recommendations from sepsis guidelines should be taken into account. Further clinical research of individualized treatment for septic cardiomyopathy is necessary.

Key words: Sepsis, Cardiomyopathies, Vasoactive agent, Catecholamines, Vasopressins, Beta-antagonists

Yina Liu, Xiaochun Ma. Selection of vasoactive agents in septic cardiomyopathy[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2020, 06(02): 128-131.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2020.02.004

https://icu.cma-cmc.com.cn/EN/Y2020/V06/I02/128

References 35

1	Beesley SJ, Weber G, Sarge T, et al. Septic Cardiomyopathy. Critical care medicine [J]. 2018, 46(4): 625-634.
2	Sato R, Kuriyama A, Takada T, et al. Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study[J]. Medicine, 2016, 95(39): e5031.
3	Jeong HS, Lee TH, Bang CH, et al. Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: A comparative retrospective study[J]. Medicine, 2018, 97(13): e0263.
4	Vieillard-Baron A, Caille V, Charron C, et al. Actual incidence of global left ventricular hypokinesia in adult septic shock[J]. Critical Care Medicine, 2008, 36(6): 1701-1706.
5	Kakihana Y, Ito T, Nakahara M, et al. Sepsis-induced myocardial dysfunction: pathophysiology and management[J]. J Intensive Care. 2016, 4: 22.
6	Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis[J]. Critical Care, 2013, 17(3): R96.
7	Sato R, Nasu M. A review of sepsis-induced cardiomyopathy[J]. J Intensive Care, 2015, 3: 48.
8	Sweeney TE, Khatri P. Septic cardiomyopathy: getting to the heart of the matter[J]. Crit Care Med, 2017, 45(3): 556-557.
9	Sanfilippo F, Orde S, Oliveri F, et al. The challenging diagnosis of septic cardiomyopathy. Chest [J]. 2019, 156(3): 635-636.
10	Martin L, Derwall M, Al Zoubi S, et al. The septic heart: current understanding of molecular mechanisms and clinical implications[J]. Chest, 2019, 155(2): 427-437.
11	Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management[J]. EurHeart J, 2018, 39(22): 2047-2062.
12	De Backer D, Pinsky M. Norepinephrine improves cardiac function during septic shock, but why?[J]. British Journal of Anaesthesia, 2018, 120(3): 421-424.
13	Hamzaoui O, Jozwiak M, Geffriaud T, et al. Norepinephrine exerts an inotropic effect during the early phase of human septic shock. British journal of anaesthesia [J]. 2018, 120(3): 517-524.
14	Annane D, Ouanes-Besbes L, de Backer D, et al. A global perspective on vasoactive agents in shock[J]. Intensive care medicine, 2018, 44(6): 833-846.
15	Rachoin JS, Dellinger RP. Timing of norepinephrine in septic patients: NOT too little too late[J]. Critical Care, 2014, 18(6):691.
16	Wilkman E, Kaukonen KM, Pettila V, etal. Association between inotrope treatment and 90-day mortality in patients with septic shock[J]. Acta Anaesthesiol Scand, 2013, 57(4): 431-442.
17	Sato R, Nasu M. Time to re-think the use of dobutamine in sepsis[J]. J Intensive Care. 2017, 5: 65.
18	Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016[J]. Intensive Care Medicine, 2017, 43(3): 304-377.
19	Nishida O, Ogura H, Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)[J]. J Intensive Care, 2018, 6: 7.
20	Zausig YA, Geilfus D, Missler G, et al. Direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in isolated septic rat hearts[J]. Shock, 2010, 34(3): 269-274.
21	Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial[J]. Lancet, 2007, 370(9588): 676-684.
22	Colling KP, Banton KL, Beilman GJ. Vasopressors in sepsis[J]. Surgical Infections, 2018, 19(2): 202-207.
23	Mahmoud KM, Ammar AS. Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock[J]. Indian J Crit Care Med, 2012,16(2): 75-80.
24	Levy B. Lactate and shock state: the metabolic view[J]. Curr Opin Crit Care, 2006, 12(4): 315-321.
25	Levy B, Dusang B, Annane D, et al. Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study[J]. Crit Care Med, 2005, 33(10): 2172-2177.
26	Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies[J]. Anesthesiology, 2006, 105(3): 599-612; quiz 39-40.
27	Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock[J]. N Engl J Med, 2008, 358(9): 877-887.
28	Mehta S, Granton J, Gordon AC, et al. Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine[J]. Critical Care, 2013, 17(3): R117.
29	29Wasilewski MA, Grisanti LA, Song J, et al. Vasopressin type 1A receptor deletion enhances cardiac contractility, beta-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction[J]. Clin Sci (Lond), 2016, 130(22): 2017-2027.
30	Radermacher P, Huber-Lang M, Thiemermann C. Catecholamines and the septic heart: opening Pandora′s box?[J]. Shock, 2013, 39(4): 404-405.
31	Tan K, Harazim M, Tang B, et al. The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review[J]. Critical Care, 2019, 23(1): 298.
32	Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial[J]. Jama, 2013, 310(16): 1683-1691.
33	Du W, Wang XT, Long Y, etal. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock[J]. Chin Med J (Engl), 2016, 129(14): 1658-1665.
34	Morelli A, Donati A, Ertmer C, et al. Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study[J]. Critical Care Medicine, 2013, 41(9): 2162-2168.
35	Ehrman RR, Sullivan AN, Favot MJ, et al. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature[J]. Critical Care, 2018, 22(1): 112.

[1]	Jianbiao Meng, Geng Zhang, Yanna Jiao. Exploratory study on early intestinal microecological changes in patients with sepsis-induced myocardial dysfunction [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(04): 279-285.
[2]	Yu Chen, Fang Feng, Lu Zhang, Jian Liu. Bioinformatics analysis to screen key pathogenic genes in septic cardiomyopathy [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(04): 286-291.
[3]	Yuanyuan Han, Sabeiti Reziya, Zhijie Mao, Aierken Mufunayi, Chen Lu, Xiaohong Sang, Mulati Aerman, Li Zhang. Effect of combined blood purification on serum inflammatory cytokines levels and clinical prognosis in patients with sepsis [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(04): 272-278.
[4]	Xiaoqiao Mo, Zheying Hu, Donghua Liao, Tian Xie. Establishment and evaluation of a predictive model for death risk in patients with acute kidney injury secondary to sepsis [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(03): 198-206.
[5]	Xiaoyan Zhang, Dongqiong Xiao, Hu Gao, Lin Chen, Fajuan Tang, Xihong Li. The protective effect and mechanism of overexpression of transcription factor 12 on the cerebral cortex of rats with sepsis-associated encephalopathy [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 540-549.
[6]	Xu Wei, Ge Zhang, Jinlin Wu. Monitoring and treatment of neonatal sepsis-induced coagulopathy [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 379-386.
[7]	Xiaodan Wang, Yuan Wang, Xiangyu Cui, Xiaolei Ren. Analysis of pathogenic bacteria resistance of drug and high risk factors of death in urogenic sepsis after endoscopic surgery for upper urinary tract stones [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 611-615.
[8]	Xuecheng Wu, Yuanwei Li, Wuxiong Yuan, Jiansong Wang, Yongzhong Shi, Qiang Lu, Zhuo Li, Jia Chen, Zhe Liu, Yili Teng, Zhiyong Gao. Diagnostic value of inflammatory mediators profile combined with procalcitonin in urogenic sepsis [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(05): 476-480.
[9]	Shangwen Dou, Huan Deng, Bangfeng Liu, Gaoyuanzhi Yue, Huacai Zhu, Yongda Liu. Role of preoperative urine culture re-examination in the prediction of infectious complications related to mini-percutaneous nephrolithotomy [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(04): 361-366.
[10]	Ruanxin Miao, Xi Qiao. Role of Toll-like receptor in sepsis-induced acute kidney injury [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(04): 210-214.
[11]	Shiming Li, Wei Huang, Ling Liu. Mechanism of high mobility group box protein 1 mediated sepsis-induced coagulopathy and treatment progress [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 269-273.
[12]	Chao Gao, Jie Chao, Haibo Qiu. Emerging roles of transcription factor T-bet of Th17 in immune imbalance of sepsis [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 280-285.
[13]	Xiang Yang, Lanqi Guo, Jianfeng Xie, Haibo Qiu. Role of metagenomics next-generation sequencing in the pathogen diagnosis in sepsis [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 292-297.
[14]	Rui Tan, Jing Wang, Jiangquan Yu, Ruiqiang Zheng. Progress in understanding of role of high density lipoprotein, apolipoprotein A-I, and serum amyloid A in sepsis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 749-753.
[15]	Xing Cai, Ruiqiang Zheng. Progress in application of heparin-binding protein in sepsis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 487-490.

Please choose a citation manager

Content to export